Johnson & Johnson $103.73

down 0.00


29/8/2014 04:00 PM  |  NYSE : JNJ  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get JNJ Trend Analysis - it has underperformed the S&P 500 by 2%

Partner Headlines

  1. U.S., U.K. ISIS Response Differ Widely

    FoxBusiness
  2. Bank Of America Remains Optimistic On Johnson & Johnson

    Benzinga
  3. Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & ...

    Benzinga
  4. Focus On A Big-Picture Purpose To Get Top Results

    IBD
  5. Think Like An Owner

    GuruFocus
  6. Late-Cycle Nirvana: Moaty Dividends on the Cheap

    YCharts
  7. The 4 Companies Teaming Up For A New Tool To Fight Cancer

    Benzinga
  8. Here's Why Johnson & Johnson Is a Good Investment at 52-Week Highs

    GuruFocus
  9. Omnicom Offers Steady Profit Growth, Rising Dividend

    IBD
  10. #PreMarket Primer: Friday, August 22: Draghi, Yellen Set To Speak At Jackson ...

    Benzinga
  11. Illumina lines up key partners

    IBD
  12. Apple Stock Held By Institutional Investors Rises

    IBD
  13. A Few Reasons Why Investors Should Consider Dendreon for Their Portfolio

    GuruFocus
  14. Robert Wood Johnson's New Industry Made Surgery Safer

    IBD
  15. Earnings Season Is The Right Prescription For Health Care ETFs

    Benzinga
  16. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  17. Medivation Cancer Drug Fuels Beat, Swings To Profit

    IBD
  18. 3 Companies That Should Benefit From The New Initiative In Africa

    Benzinga
  19. #PreMarket Primer: Thursday, August 7: Russia Set To Release A List Of ...

    Benzinga
  20. 5 Dividend Stocks Delivering The Secret To Successful Investing

    GuruFocus
  21. 5 Dividend Stocks Delivering The Secret To Successful Investing

    GuruFocus
  22. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD
  23. Why Procter & Gamble Surged Higher On Friday?

    GuruFocus
  24. Outlook for August 2014

    GuruFocus
  25. Pharmacyclics Q2 Earnings Get Mixed Reception

    IBD
  26. Unique 3D Startups And The Public Companies That Should Buy Them

    Benzinga
  27. Merck, J&J, Baxter Provide Healthy Dividend Stream

    IBD
  28. Limiting Risk: A Little Exposure To High Yield Goes A Long Way

    GuruFocus
  29. What's the Right PE Ratio?

    GuruFocus
  30. Omnicom Tops Forecasts Despite Failed Publicis Merger

    IBD
  31. BlackRock: Stocks Iffy, But Not These Pockets

    YCharts
  32. YTD Biggest Buyback Companies Trailing S&P In Stock Appreciation

    Benzinga
  33. Just Post-It: 3M Is a Good Bet for Your Portfolio Today

    GuruFocus
  34. Organovo Up 19% #PreMarket; In Research Pact With Johnson & Johnson Unit

    Benzinga
  35. ...

    GuruFocus
  36. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  37. The 10 Most-Respected Corporate Brands

    Benzinga
  38. Stocks To Watch For July 22, 2014

    Benzinga
  39. Why Has Wall Street Punished Johnson & Johnson For Its Earnings Beat?

    Benzinga
  40. #PreMarket Primer: Friday, July 18: Tension Between Russia And The West ...

    Benzinga
  41. Johnson & Johnson CEO: No Plans to Leave U.S.

    FoxBusiness
  42. Which Matters More: Janet Yellen Or Earnings & Economic Data?

    Benzinga
  43. Morgan Stanley Sees Meaningful '15 Headwind For Johnson & Johnson

    Benzinga
  44. Video; J&J Earnings Beat Estimates, But Guidance Mixed

    IBD
  45. Goldman Sachs, JPMorgan Chase Report Strong Earnings; Retail Numbers Fall ...

    Benzinga
  46. U.S. Stocks Sink; JPMorgan Shares Surge On Upbeat Earnings

    Benzinga
  47. J&J Earnings Beat Estimates, But Guidance Mixed

    IBD
  48. Markets Rise; Goldman Sachs Profit Beats Estimates

    Benzinga
  49. Stock Indexes Open Higher, Then Sag To Near Break-Even

    IBD
  50. Johnson & Johnson, Goldman Sachs Pushing These ETFs Upward

    Benzinga
Trading Center